CONTROLLED DRUG RELEASE FORMULATION
Pharmaceutical formulation dosage form (1) with a core (2) encapsulated by at least one shell (3) and comprising at least one active pharmaceutical ingredient (4), wherein the at least one active pharmaceutical ingredient (4) is embedded in said core (2) of the pharmaceutical formulation dosage form...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | IMANIDIS Georgios LIPPS Georg LANZ Michael PAREDES Valeria |
| description | Pharmaceutical formulation dosage form (1) with a core (2) encapsulated by at least one shell (3) and comprising at least one active pharmaceutical ingredient (4), wherein the at least one active pharmaceutical ingredient (4) is embedded in said core (2) of the pharmaceutical formulation dosage form (1), preferably in that said core (2) is formed by a matrix based on xyloglucan (5) containing said active pharmaceutical ingredient (4), and wherein said shell (3) is a pH-responsive coating.
Forma de dosificación de formulación farmacéutica (1) con un núcleo (2) encapsulado por al menos una cubierta (3) y que comprende al menos un ingrediente farmacéutico (4) activo, en donde el al menos un ingrediente farmacéutico (4) activo está incrustado en dicho núcleo (2) de la forma de dosificación de formulación farmacéutica (1), preferiblemente porque dicho núcleo (2) está formado por una matriz a base de xiloglucano (5) que contiene dicho ingrediente farmacéutico (4) activo, y en donde dicha cubierta (3) es un recubrimiento sensible al pH. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2021002686A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2021002686A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2021002686A3</originalsourceid><addsrcrecordid>eNrjZFB29vcLCfL38XF1UXAJCnVXCHL1cXUMdlVw8w_yDfVxDPH09-NhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfG-EUYGRoYGBkZmFmaOxkQpAgCy1CNj</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CONTROLLED DRUG RELEASE FORMULATION</title><source>esp@cenet</source><creator>IMANIDIS Georgios ; LIPPS Georg ; LANZ Michael ; PAREDES Valeria</creator><creatorcontrib>IMANIDIS Georgios ; LIPPS Georg ; LANZ Michael ; PAREDES Valeria</creatorcontrib><description>Pharmaceutical formulation dosage form (1) with a core (2) encapsulated by at least one shell (3) and comprising at least one active pharmaceutical ingredient (4), wherein the at least one active pharmaceutical ingredient (4) is embedded in said core (2) of the pharmaceutical formulation dosage form (1), preferably in that said core (2) is formed by a matrix based on xyloglucan (5) containing said active pharmaceutical ingredient (4), and wherein said shell (3) is a pH-responsive coating.
Forma de dosificación de formulación farmacéutica (1) con un núcleo (2) encapsulado por al menos una cubierta (3) y que comprende al menos un ingrediente farmacéutico (4) activo, en donde el al menos un ingrediente farmacéutico (4) activo está incrustado en dicho núcleo (2) de la forma de dosificación de formulación farmacéutica (1), preferiblemente porque dicho núcleo (2) está formado por una matriz a base de xiloglucano (5) que contiene dicho ingrediente farmacéutico (4) activo, y en donde dicha cubierta (3) es un recubrimiento sensible al pH.</description><language>eng ; spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210811&DB=EPODOC&CC=MX&NR=2021002686A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210811&DB=EPODOC&CC=MX&NR=2021002686A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IMANIDIS Georgios</creatorcontrib><creatorcontrib>LIPPS Georg</creatorcontrib><creatorcontrib>LANZ Michael</creatorcontrib><creatorcontrib>PAREDES Valeria</creatorcontrib><title>CONTROLLED DRUG RELEASE FORMULATION</title><description>Pharmaceutical formulation dosage form (1) with a core (2) encapsulated by at least one shell (3) and comprising at least one active pharmaceutical ingredient (4), wherein the at least one active pharmaceutical ingredient (4) is embedded in said core (2) of the pharmaceutical formulation dosage form (1), preferably in that said core (2) is formed by a matrix based on xyloglucan (5) containing said active pharmaceutical ingredient (4), and wherein said shell (3) is a pH-responsive coating.
Forma de dosificación de formulación farmacéutica (1) con un núcleo (2) encapsulado por al menos una cubierta (3) y que comprende al menos un ingrediente farmacéutico (4) activo, en donde el al menos un ingrediente farmacéutico (4) activo está incrustado en dicho núcleo (2) de la forma de dosificación de formulación farmacéutica (1), preferiblemente porque dicho núcleo (2) está formado por una matriz a base de xiloglucano (5) que contiene dicho ingrediente farmacéutico (4) activo, y en donde dicha cubierta (3) es un recubrimiento sensible al pH.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB29vcLCfL38XF1UXAJCnVXCHL1cXUMdlVw8w_yDfVxDPH09-NhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfG-EUYGRoYGBkZmFmaOxkQpAgCy1CNj</recordid><startdate>20210811</startdate><enddate>20210811</enddate><creator>IMANIDIS Georgios</creator><creator>LIPPS Georg</creator><creator>LANZ Michael</creator><creator>PAREDES Valeria</creator><scope>EVB</scope></search><sort><creationdate>20210811</creationdate><title>CONTROLLED DRUG RELEASE FORMULATION</title><author>IMANIDIS Georgios ; LIPPS Georg ; LANZ Michael ; PAREDES Valeria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2021002686A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>IMANIDIS Georgios</creatorcontrib><creatorcontrib>LIPPS Georg</creatorcontrib><creatorcontrib>LANZ Michael</creatorcontrib><creatorcontrib>PAREDES Valeria</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IMANIDIS Georgios</au><au>LIPPS Georg</au><au>LANZ Michael</au><au>PAREDES Valeria</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CONTROLLED DRUG RELEASE FORMULATION</title><date>2021-08-11</date><risdate>2021</risdate><abstract>Pharmaceutical formulation dosage form (1) with a core (2) encapsulated by at least one shell (3) and comprising at least one active pharmaceutical ingredient (4), wherein the at least one active pharmaceutical ingredient (4) is embedded in said core (2) of the pharmaceutical formulation dosage form (1), preferably in that said core (2) is formed by a matrix based on xyloglucan (5) containing said active pharmaceutical ingredient (4), and wherein said shell (3) is a pH-responsive coating.
Forma de dosificación de formulación farmacéutica (1) con un núcleo (2) encapsulado por al menos una cubierta (3) y que comprende al menos un ingrediente farmacéutico (4) activo, en donde el al menos un ingrediente farmacéutico (4) activo está incrustado en dicho núcleo (2) de la forma de dosificación de formulación farmacéutica (1), preferiblemente porque dicho núcleo (2) está formado por una matriz a base de xiloglucano (5) que contiene dicho ingrediente farmacéutico (4) activo, y en donde dicha cubierta (3) es un recubrimiento sensible al pH.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX2021002686A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CONTROLLED DRUG RELEASE FORMULATION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T08%3A54%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IMANIDIS%20Georgios&rft.date=2021-08-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2021002686A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |